DOCSLIB.ORG

Fatty Acids & Derivatives

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Fatty Acids & Derivatives Conditions of Sale Validity The Conditions of Sale apply to the written text in this Catalogue superseding earlier texts related to such conditions. Intention of Use Our products are intended for research purposes only. Prices See under Order Information. All prices in this catalogue are net prices in Euro, ex works. Taxes, shipping costs or other external costs demanded by the buyer are invoiced. Delivery See under Order Information – shipping terms. Payment terms Payment terms are normally net 30 days. Deductions are not accepted unless we have issued a credit note. We accept payment by credit card (Visa/ Mastercard), bank transfer (wiring) or by cheque. If payment by cheque we will add a bank fee to our invoice. Complaints Complaints about a product or products must be made inside 30 days from the invoice date. All claims must specify batch (lot) and invoice numbers. Return of goods will not be accepted unless authorized by us. Insurance Insurance will not be made unless otherwise instructed. Delays We cannot accept compensation claims due to delays or non-deliveries. We reserve us the right to withdraw from delivery due to long term shortage of starting materials, production breakdown or other circumstances beyond our control. Warranty and All products in this catalogue are warranted to be free of defects and in Compensation Claims accordance with given specifications. If this warranty does not comply with specifications, any indemnities will be limited to not exceed the price paid for the goods. Acceptance Placing of an order implies acceptance of our conditions of sale. We accept credit cards (Visa/ Mastercard) www.larodan.se [email protected] +46 40 16 41 55 1 Ordering Information You can easily order from Larodan – please contact our local distributor or us by phone, e-mail, fax or letter. Visiting & Mailing Larodan Fine Chemicals AB Phone 040-164155 nat address Limhamnsgårdens allé 9 +46 40164155 int SE-216 16 Malmö e-mail [email protected] Sweden Fax 040-155498 nat +46 40155498 web site www.larodan.se Placing your Order To speed up handling of orders, please indicate the following – Product catalogue number – Description – Size. EU Vat number – if you are located inside the EU. Order acknowledgement Normally we do not acknowledge incoming orders. If you want us to acknowledge your order – please indicate that. Prices All prices are quoted in Euro and are subject to change without notice. However, if the price of any item has been changed by more than 10%, we will notify you before processing your order. Shipping terms Delivery terms are FOB Malmö. We ship by courier, registered mail or parcel post if not otherwise instructed. If not shipped collect we prepay the freight charge and add it to our invoice. 2 www.larodan.se [email protected] +46 40 16 41 55 Contents Alphabetical Index Page no Acyl-L-Carnitines • Native 52-53 • Deuterium Labelled 53-54 Bile Acids & Methyl Esters 132 Cholesterol & Esters 96 Coenzyme A & Fatty Acid CoA Esters 55-56 Conjugated Linoleic Acids (CLA) • Analytical Standards 18 • FFA/ Esters/ Triglycerides in bulk 27-28 Dicarboxylic Acids & Dimethyl Esters 102-104 Dolichols & Phosphates 130 Eicosanoids 49-51 Fatty Acids & Methyl Esters – straight chain • Saturated & Unsaturated 6-18 • EPA & DHA Esters in bulk 26 Fatty Acids - Unusual / Methyl Esters 19-26 • Conjugated Polyene 19-20 • Odd-Numbered Polyunsaturated 21-22 • Other Unusual 22-26 Fatty Acids & Methyl Esters – methyl branched/ cyclopropyl 57-62 • Phytanic & Pristanic – Native and Deuterium labelled 57 • Iso & Anteiso 57-61 • 10-methyl Branched 62 • Cyclopropyl 62 Fatty Acids & Methyl Esters – Oxygenated/ Oxylipin related 45-48 • Hydroxy 45-46 • Dihydroxy 48 • Epoxy 47 • Oxo 46-47 Fatty Acids & Methyl Esters – Hydroxy (synthetic) 63-68 • 2-Hydroxy 63-64 • 3-Hydroxy 65-67 • Omega-Hydroxy 67-68 • Other Microbiological 68 www.larodan.se [email protected] +46 40 16 41 55 3 Fatty Acids – Deuterium labelled • Perdeuterated 87-88 • α-Deuterated 88-89 • ω-Deuterated 89-90 • Polyunsaturated 90 • Miscellaneous 90 Fatty Acids – 13C labelled 92 Fatty Alcohols 94-95 Gangliosides & Derivatives 123-124 Glycerides • Monoglycerides - Saturated/ Unsaturated 69-72 • Diglycerides – Single/ Mixed Fatty Acids 73-78 • Triglycerides - Single/ Mixed Fatty Acids 79-86 • Triglycerides – 13C-Labelled 93 Hydrocarbons • Aliphatic 133-135 • Isoprenoid 135 Kits • Fatty Acids/ Methyl Esters 136-139 • Glycerides 140 • Aliphatic Hydrocarbons 140 • Phosphoglycerides 141 • Phospholipids 141 • Plant Sterols 141 Larodan Reference Mixtures • Glycoshingolipid Mixtures • FAME Mixtures 142 • Oil Mixtures 142-151 • Methyl Branched FAME Mixtures 145-146 • Glyceride Mixtures 156 • Mixed Lipid Mixtures 148-149 • Polar Lipids Mixture 159 • Polyprenol Mixtures 158 • Free Fatty Acid Mixtures 153 • n-Paraffin Mixture 159 • Fish Oil FAME Mixture 157 Metabolic Research Products • Long Chain Fatty Acids – Deuteriumlabelled 91 • Acylglycines/ Miscellaneous – 13C/ Deuteriumlabelled 93 Oligoprenyl Phosphates 131 4 www.larodan.se [email protected] +46 40 16 41 55 Oxylipines 28-44 • Hydroperoxides 31-32 • Hydroxides 32-35 • Ketones 35-36 • Epoxides 36-38 • Diols 38-39 • Allene-Oxide-Synthase- -derived 39-40 • Divinyl-Ether-Synthase- -derived 40-41 • Epoxy Alcohol Synthase–/ Peroxygenase-derived 41-44 • Lyase-derived 44 • Others 44 D-myo-Phosphatidylinositol Phosphates 125-126 Phospholipids • Natural PC, PE, PI, PA, PG, CL, PS, LPC, LPE, LPI, LPG 105-109 • Semisynthetic GPC, PC, PE, PA, PG, PS, LPC, LPG 110-113 • Deuterium Labelled 90 • Di-O-Alkyl 114 Plant Leaf Lipids 126 Plant Sterols & Steryl Glucosides 126 Plasmalogens 109 Polyprenols & Monophosphates 127-129 Sialic Acid & Derivatives 124 Sphingolipids 115-122 • Sphingosines 115-116 • Ceramides 116-119 • Cerebrosides 119-120 • Sphingomyelins 121 • Fluorescent 122 Wax Esters C12-C20 97-102 www.larodan.se [email protected] +46 40 16 41 55 5 Nomenclature – Geometrical Isomers In this catalogue we use two systems to descibe the geometry of structures having carbon-carbon double bonds (geometric isomers). Cis/ trans denomination is used to indicate C=C configuration of common unsaturated fatty acids of natural origin, i.e. from vegetable and animal fats and oils. A more distinct nomenclature , the Z/E-system, was introduced in the 1950´s by Cahn, Ingold and Prelog. For fatty acids and derivatives cis is equivalent to Z and trans to E, which is not always the case for other kinds of molecules. Fatty Acids & Derivatives Saturated n-Fatty Acids (n-Carboxylic) Bulk discounts are available on larger quantities. Other esters, such as ethyl esters can be offered on request Saturated and unsaturated fatty acids occur, as triglycerides, mainly in plants and animals, such as in oil bearing seeds and fruits, tallow, lard and marine oils. In natural fats and oils, even numbered fatty acids are the predominant ones - odd numbered are rare. Larodan provides a growing range of high purity fatty acids and esters for research and analytical purposes. In this catalogue you will find new lines of fatty acids and metabolites under special headings. Please visit our web site for the latest news – www.larodan.se. Propionic Acid Size Order no EUR No. of C: 3:0 Mw: 74.08 Documentation: GC Purity: 99+% 100 mg 10-0300-9 8 1 g 10-0300-13 11 10 g 10-0300-17 40 Butyric Acid No. of C: 4:0 Mw: 88.11 Documentation: GC Purity: 99+% 100 mg 10-0400-9 8 1 g 10-0400-13 11 10 g 10-0400-17 40 Pentanoic Acid No. of C: 5:0 Mw: 102.14 Documentation: GC Purity: 99+% 100 mg 10-0500-9 8 1 g 10-0500-13 11 10 g 10-0500-17 40 Hexanoic Acid (Caproic Acid) No. of C: 6:0 Mw: 116.16 Documentation: GC Purity: 99+% 100 mg 10-0600-9 8 1 g 10-0600-13 11 10 g 10-0600-17 40 Heptanoic Acid No. of C: 7:0 Mw: 130.19 Documentation: GC Purity: 99+% 100 mg 10-0700-9 10 1 g 10-0700-13 36 5 g 10-0700-16 135 Octanoic Acid (Caprylic Acid) No. of C: 8:0 Mw: 144.22 Documentation: GC Purity: 99+% 100 mg 10-0800-9 8 1 g 10-0800-13 11 10 g 10-0800-17 40 6 www.larodan.se [email protected] +46 40 16 41 55 Nonanoic Acid (Pelargonic Acid) No. of C: 9:0 Mw: 158.24 Documentation: GC Purity: 99+% 100 mg 10-0900-9 10 1 g 10-0900-13 36 5 g 10-0900-16 135 Decanoic Acid (Capric Acid) No. of C: 10:0 Mw: 172.27 Documentation: GC Purity: 99+% 100 mg 10-1000-9 8 1 g 10-1000-13 11 10 g 10-1000-17 40 Undecanoic Acid No. of C: 11:0 Mw: 186.30 Documentation: GC Purity: 99+% 100 mg 10-1100-9 10 1 g 10-1100-13 36 5 g 10-1100-16 135 Dodecanoic Acid (Lauric Acid) No. of C: 12:0 Mw: 200.33 Documentation: GC Purity: 99+% 100 mg 10-1200-9 8 1 g 10-1200-13 11 10 g 10-1200-17 40 Tridecanoic Acid No. of C: 13:0 Mw: 214.35 Documentation: GC Purity: 99+% 100 mg 10-1300-9 10 1 g 10-1300-13 36 5 g 10-1300-16 135 Tetradecanoic Acid (Myristic Acid) No. of C: 14:0 Mw: 228.38 Documentation: GC Purity: 99+% 100 mg 10-1400-9 8 1 g 10-1400-13 11 10 g 10-1400-17 40 Pentadecanoic Acid No. of C: 15:0 Mw: 242.41 Documentation: GC Purity: 99+% 100 mg 10-1500-9 10 1 g 10-1500-13 36 5 g 10-1500-16 135 Hexadecanoic Acid (Palmitic Acid) No. of C: 16:0 Mw: 256.43 Documentation: GC Purity: 99+% 100 mg 10-1600-9 8 1 g 10-1600-13 11 10 g 10-1600-17 40 Heptadecanoic Acid (Margaric Acid) No.
Load more

Recommended publications
  • Sigma Fatty Acids, Glycerides, Oils and Waxes
    Sigma Fatty Acids, Glycerides, Oils and Waxes Library Listing – 766 spectra This library represents a material-specific subset of the larger Sigma Biochemical Condensed Phase Library relating to relating to fatty acids, glycerides, oils, and waxes found in the Sigma Biochemicals and Reagents catalog. Spectra acquired by Sigma-Aldrich Co. which were examined and processed at Thermo Fisher Scientific. The spectra include compound name, molecular formula, CAS (Chemical Abstract Service) registry number, and Sigma catalog number. Sigma Fatty Acids, Glycerides, Oils and Waxes Index Compound Name Index Compound Name 464 (E)-11-Tetradecenyl acetate 592 1-Monocapryloyl-rac-glycerol 118 (E)-2-Dodecenedioic acid 593 1-Monodecanoyl-rac-glycerol 99 (E)-5-Decenyl acetate 597 1-Monolauroyl-rac-glycerol 115 (E)-7,(Z)-9-Dodecadienyl acetate 599 1-Monolinolenoyl-rac-glycerol 116 (E)-8,(E)-10-Dodecadienyl acetate 600 1-Monolinoleoyl-rac-glycerol 4 (E)-Aconitic acid 601 1-Monomyristoyl-rac-glycerol 495 (E)-Vaccenic acid 598 1-Monooleoyl-rac-glycerol 497 (E)-Vaccenic acid methyl ester 602 1-Monopalmitoleoyl-rac-glycerol 98 (R)-(+)-2-Chloropropionic acid methyl 603 1-Monopalmitoyl-rac-glycerol ester 604 1-Monostearoyl-rac-glycerol; 1- 139 (Z)-11-Eicosenoic anhydride Glyceryl monosterate 180 (Z)-11-Hexadecenyl acetate 589 1-O-Hexadecyl-2,3-dipalmitoyl-rac- 463 (Z)-11-Tetradecenyl acetate glycerol 181 (Z)-3-Hexenyl acetate 588 1-O-Hexadecyl-rac-glycerol 350 (Z)-3-Nonenyl acetate 590 1-O-Hexadecyl-rac-glycerol 100 (Z)-5-Decenyl acetate 591 1-O-Hexadecyl-sn-glycerol
    [Show full text]
  • Edible Liquid Marbles and Capsules Covered with Lipid Crystals
    Journal of Oleo Science Copyright ©2012 by Japan Oil Chemists’ Society J. Oleo Sci. 61, (9) 477-482 (2012) Edible Liquid Marbles and Capsules Covered with Lipid Crystals Yuki Kawamura1, Hiroyuki Mayama2 and Yoshimune Nonomura1＊ 1 Department of Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University ( 4-3-16 Jonan, Yonezawa 992- 8510, JAPAN) 2 Research Institute for Electronic Science, Hokkaido University ( N21W10, Sapporo 001-0021, JAPAN) Abstract: Liquid marbles are water droplets covered with solid particles. Here we show a method for the preparation of edible liquid marbles and capsules covered with fatty acid crystals and triacylglycerol crystals. We prepared liquid marbles using a simple method; namely, a water droplet was rolled on lipid crystals in petri dishes. The resulting marbles were converted to capsules covered with a lipid shell by heating. These marbles were stable not only on glass surfaces but also on water surfaces because they had rigid hydrophobic exteriors. The lifetime of the liquid marbles on water depended on the alkyl chain length of the lipid molecules and the pH of the water. These findings are useful for applying liquid marbles to food, cosmetic, and medical products. Key words: Liquid marble, Hydrophobic material, Fatty acid, Triacylglycerol 1 INTRODUCTION oral formulations becomes possible. Liquid marbles and dry water are water droplets covered Here, we propose a method for the preparation of liquid with solid particles such as hydrophobic silica and fluorine marbles covered with fatty acid crystals and triacylglycerol resin particles; here, liquid marbles are macroscopic single crystals because these lipid crystals are suitable stabilizing water droplets, while dry water is a white powder contain- agents for edible liquid marbles.
    [Show full text]
  • Harvest Season Significantly Influences the Fatty Acid
    biology Article Harvest Season Significantly Influences the Fatty Acid Composition of Bee Pollen Saad N. Al-Kahtani 1 , El-Kazafy A. Taha 2,* , Soha A. Farag 3, Reda A. Taha 4, Ekram A. Abdou 5 and Hatem M Mahfouz 6 1 Arid Land Agriculture Department, College of Agricultural Sciences & Foods, King Faisal University, P.O. Box 400, Al-Ahsa 31982, Saudi Arabia; [email protected] 2 Department of Economic Entomology, Faculty of Agriculture, Kafrelsheikh University, Kafrelsheikh 33516, Egypt 3 Department of Animal and Poultry Production, Faculty of Agriculture, University of Tanta, Tanta 31527, Egypt; [email protected] 4 Agricultural Research Center, Bee Research Department, Plant Protection Research Institute, Dokki, Giza, Egypt; [email protected] 5 Agricultural Research Center, Plant Protection Research Institute, Dokki, Giza, Egypt; [email protected] 6 Department of Plant Production, Faculty of Environmental Agricultural Sciences, Arish University, Arish 45511, Egypt; [email protected] * Correspondence: elkazafi[email protected] Simple Summary: Harvesting pollen loads collected from a specific botanical origin is a complicated process that takes time and effort. Therefore, we aimed to determine the optimal season for harvesting pollen loads rich in essential fatty acids (EFAs) and unsaturated fatty acids (UFAs) from the Al- Ahsa Oasis in eastern Saudi Arabia. Pollen loads were collected throughout one year, and the Citation: Al-Kahtani, S.N.; tested samples were selected during the top collecting period in each season. Lipids and fatty acid Taha, E.-K.A.; Farag, S.A.; Taha, R.A.; composition were determined. The highest values of lipids concentration, linolenic acid (C ), Abdou, E.A.; Mahfouz, H.M Harvest 18:3 Season Significantly Influences the stearic acid (C18:0), linoleic acid (C18:2), arachidic acid (C20:0) concentrations, and EFAs were obtained Fatty Acid Composition of Bee Pollen.
    [Show full text]
  • 01 Excipients Prelims 1..9
    Triolein 757 and tablets). Included in the Canadian List of Acceptable Non- 3 Steurnagel CR. Latex emulsions for controlled drug delivery. McGinity medicinal Ingredients. JW, ed. Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms. New York: Marcel Dekker, 1989; 1–61. 4 Gutierrez-Rocca JC, McGinity JW. Influence of aging on the physical– 17 Related Substances mechanical properties of acrylic resin films cast from aqueous Acetyltributyl citrate; acetyltriethyl citrate; tributyl citrate. dispersions and organic solutions. Drug Dev Ind Pharm 1993; 19(3): 315–332. 5 Liu J, Williams R. Properties of heat-humidity cured cellulose acetate 18 Comments phthalate free films. Eur J Pharm Sci 2002; 17(1–2): 31–41. 6 Lewis RJ, ed. Sax’s Dangerous Properties of Industrial Materials, 11th A specification for triethyl citrate is contained in the Food (7) edn. New York: Wiley, 2004; 3546. Chemicals Codex (FCC). 7 Food Chemicals Codex, 6th edn. Bethesda, MD: United States The EINECS number for triethyl citrate is 201-070-7. The Pharmacopeia, 2008; 988. PubChem Compound ID (CID) for triethyl citrate is 6506. 20 General References 19 Specific References Vertellus Specialties Inc. Technical data sheet: Citroflex 2, 2007. 1 Gutierrez-Rocca JC, McGinity JW. Influence of water soluble and insoluble plasticizers on the physical and mechanical properties of 21 Author acrylic resin copolymers. Int J Pharm 1994; 103: 293–301. J Teckoe. 2 Lehmann K. Chemistry and application properties of polymethacrylate coating systems. McGinity JW, ed. Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms. New York: Marcel Dekker, 1989; 153– 22 Date of Revision 245. 24 February 2009. Triolein 1 Nonproprietary Names 6 Functional Category None adopted.
    [Show full text]
  • Intravenous Treatment with a Long-Chain Omega-3 Lipid Emulsion Provides Neuroprotection in a Murine Model of Ischemic Stroke – a Pilot Study
    RESEARCH ARTICLE Intravenous Treatment with a Long-Chain Omega-3 Lipid Emulsion Provides Neuroprotection in a Murine Model of Ischemic Stroke ± A Pilot Study Dirk Berressem1*, Konrad Koch1, Nicole Franke1, Jochen Klein1, Gunter P. Eckert1,2 1 Goethe-University of Frankfurt, Department of Pharmacology, Germany, 2 Justus-Liebig-University Giessen, Institute of Nutritional Sciences, Germany * [email protected] a11111 Abstract Single long-chain omega-3 fatty acids (e.g. docosahexaenoic acid (DHA) or eicosapentae- noic acid (EPA)) are known for their neuroprotective properties associated with ischemic stroke. This pilot study aimed to test the effectiveness of an acute treatment with a long- OPEN ACCESS chain omega-3 lipid emulsion (Omegaven 10%®, OGV) that contains fish oil (DHA 18 mg/ Citation: Berressem D, Koch K, Franke N, Klein J, Eckert GP (2016) Intravenous Treatment with a ml; EPA 21 mg/ml) and α-tocopherol (0.2 mg/ml) in a transient middle cerebral artery occlu- Long-Chain Omega-3 Lipid Emulsion Provides sion (MCAO) model of ischemic stroke in mice. For this purpose, female CD-1 mice were Neuroprotection in a Murine Model of Ischemic anesthetized and subjected to 90 minutes of MCAO. To reflect a clinically relevant situation Stroke ± A Pilot Study. PLoS ONE 11(11): for an acute treatment, either after induction of stroke or after reperfusion, a single dose of e0167329. doi:10.1371/journal.pone.0167329 OGV was injected intravenously into the tail vein (5 ml/kg b.w.). A neurological severity Editor: Muzamil Ahmad, Indian Institute of score was used to assess motor function and neurological outcome.
    [Show full text]
  • Official Journal of the European Communities on the Hygiene Of
    No L 21 /42 EN Official Journal of the European Communities 27 . 1 . 96 COMMISSION DIRECTIVE 96/3/EC of 26 January 1 996 granting a derogation from certain provisions of Council Directive 93/43/EEC on the hygiene of foodstuffs as regards the transport of bulk liquid oils and fats by sea (Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES, whereas the measures provided for in this Directive are in compliance with the opinion of the Standing Having regard to the Treaty establishing the European Committee for Foodstuffs, Community, Having regard to Council Directive 93/43/EEC of 14 June 1993 on the hygiene of foodstuffs ('), and in parti­ HAS ADOPTED THIS DIRECTIVE : cular Article 3 (3) thereof, Whereas information shows that the application of the second subparagraph of paragraph 2 of Chapter IV of the Article 1 Annex to Directive 93/43/EEC relating to the transport of bulk foodstuffs in liquid, granulate or powdered form in This Directive derogates from the second subparagraph of receptacles and/or containers/tankers reserved for the paragraph 2 of Chapter IV of the Annex to Directive transport of foodstuffs, is not practical and imposes an 93/43/EEC and lays down equivalent conditions to ensure unduly onerous burden on food business when applied to the protection of public health and the safety and whole­ the transport in sea-going vessels of liquid oils and fats someness of the foodstuffs concerned . intended for, or likely to be used for, human consump­ tion ; Article 2 Whereas, however, it is necessary to ensure that the granting of a derogation provides equivalent protection to public health, by attaching conditions to the terms of 1 .
    [Show full text]
  • Triheptanoin for Glucose Transporter Type I Deficiency (G1D) Modulation of Human Ictogenesis, Cerebral Metabolic Rate, and Cognitive Indices by a Food Supplement
    Research Original Investigation Triheptanoin for Glucose Transporter Type I Deficiency (G1D) Modulation of Human Ictogenesis, Cerebral Metabolic Rate, and Cognitive Indices by a Food Supplement Juan M. Pascual, MD, PhD; Peiying Liu, PhD; Deng Mao, BS; Dorothy I. Kelly, MA; Ana Hernandez, MS; Min Sheng, PhD; Levi B. Good, PhD; Qian Ma, MD, PhD; Isaac Marin-Valencia, MD, MS; Xuchen Zhang, MD; Jason Y. Park, MD, PhD; Linda S. Hynan, PhD; Peter Stavinoha, PhD; Charles R. Roe, MD; Hanzhang Lu, PhD Supplemental content at IMPORTANCE Disorders of brain metabolism are multiform in their mechanisms and jamaneurology.com manifestations, many of which remain insufficiently understood and are thus similarly treated. Glucose transporter type I deficiency (G1D) is commonly associated with seizures and with electrographic spike-waves. The G1D syndrome has long been attributed to energy (ie, adenosine triphosphate synthetic) failure such as that consequent to tricarboxylic acid (TCA) cycle intermediate depletion. Indeed, glucose and other substrates generate TCAs via anaplerosis. However, TCAs are preserved in murine G1D, rendering energy-failure inferences premature and suggesting a different hypothesis, also grounded on our work, that consumption of alternate TCA precursors is stimulated and may be detrimental. Second, common ketogenic diets lead to a therapeutically counterintuitive reduction in blood glucose available to the G1D brain and prove ineffective in one-third of patients. OBJECTIVE To identify the most helpful outcomes for treatment evaluation and to uphold (rather than diminish) blood glucose concentration and stimulate the TCA cycle, including anaplerosis, in G1D using the medium-chain, food-grade triglyceride triheptanoin. DESIGN, SETTING, AND PARTICIPANTS Unsponsored, open-label cases series conducted in an academic setting.
    [Show full text]
  • TC-90 High Gamma Mixed Tocopherols
    TC-90 High Gamma Mixed Tocopherols Cambridge Commodities Chemwatch Hazard Alert Code: 2 Part Number: P28128 Issue Date: 24/07/2019 Version No: 2.5.22.11 Print Date: 23/09/2021 Safety data sheet according to REACH Regulation (EC) No 1907/2006, as amended by UK REACH Regulations SI 2019/758 S.REACH.GB.EN SECTION 1 Identification of the substance / mixture and of the company / undertaking 1.1. Product Identifier Product name TC-90 High Gamma Mixed Tocopherols Chemical Name Not Applicable Synonyms Not Available ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. (contains gamma-tocopherol, beta-tocotrienol, delta- Proper shipping name tocopherol, sunflower oil and alpha-tocopherol) Chemical formula Not Applicable Other means of P28128 identification 1.2. Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses Use according to manufacturer's directions. Uses advised against Not Applicable 1.3. Details of the supplier of the safety data sheet Registered company name Cambridge Commodities Address Lancaster Way Business Park, Ely, Cambridgeshire Cambridgeshire CB6 3NX United Kingdom Telephone +44 1353 667258 Fax Not Available Website Not Available Email [email protected] 1.4. Emergency telephone number Association / Organisation Not Available Emergency telephone Not Available numbers Other emergency Not Available telephone numbers Product code: P28128 Version No: 2.5.22.2 Page 1 of 25 S.REACH.GB.EN Lancaster Way Business Park Safety Data Sheet (Conforms to Regulation (EU) No 2020/878) Ely, Cambridgeshire, CB6 3NX, UK. Chemwatch: 9-596035 +44 (0) 1353 667258 Issue Date: 24/07/2019 [email protected] Print Date: 23/09/2021 www.c-c-l.com SECTION 2 Hazards identification 2.1.
    [Show full text]
  • Download PDF (Inglês)
    Brazilian Journal of Chemical ISSN 0104-6632 Printed in Brazil Engineering www.scielo.br/bjce Vol. 34, No. 03, pp. 659 – 669, July – September, 2017 dx.doi.org/10.1590/0104-6632.20170343s20150669 FATTY ACIDS PROFILE OF CHIA OIL-LOADED LIPID MICROPARTICLES M. F. Souza1, C. R. L.Francisco1; J. L. Sanchez2, A. Guimarães-Inácio2, P. Valderrama2, E. Bona2, A. A. C. Tanamati1, F. V. Leimann2 and O. H. Gonçalves2* 1Universidade Tecnológica Federal do Paraná, Departamento de Alimentos, Via Rosalina Maria dos Santos, 1233, Caixa Postal 271, 87301-899 Campo Mourão, PR, Brasil. Phone/Fax: +55 (44) 3518-1400 2Universidade Tecnológica Federal do Paraná, Programa de Pós-Graduação em Tecnologia de Alimentos, Via Rosalina Maria dos Santos, 1233, Caixa Postal 271, 87301-899 Campo Mourão, PR, Brasil. Phone/Fax: +55 (44) 3518-1400 *E-mail: [email protected] (Submitted: October 14, 2015; Revised: August 25, 2016; Accepted: September 6, 2016) ABSTRACT - Encapsulation of polyunsaturated fatty acid (PUFA)is an alternative to increase its stability during processing and storage. Chia (Salvia hispanica L.) oil is a reliable source of both omega-3 and omega-6 and its encapsulation must be better evaluated as an effort to increase the number of foodstuffs containing PUFAs to consumers. In this work chia oil was extracted and encapsulated in stearic acid microparticles by the hot homogenization technique. UV-Vis spectroscopy coupled with Multivariate Curve Resolution with Alternating Least-Squares methodology demonstrated that no oil degradation or tocopherol loss occurred during heating. After lyophilization, the fatty acids profile of the oil-loaded microparticles was determined by gas chromatography and compared to in natura oil.
    [Show full text]
  • Process for Preparing an Acetoglyceride
    (19) TZZ_¥_T (11) EP 1 838 656 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C07C 67/02 (2006.01) C07C 67/08 (2006.01) 04.11.2015 Bulletin 2015/45 (86) International application number: (21) Application number: 06700787.2 PCT/NL2006/050009 (22) Date of filing: 13.01.2006 (87) International publication number: WO 2006/091096 (31.08.2006 Gazette 2006/35) (54) PROCESS FOR PREPARING AN ACETOGLYCERIDE COMPOSITION COMPRISING HIGH AMOUNTS OF MONOACETYL MONOACYL GLYCERIDES VERFAHREN ZUR HERSTELLUNG EINER ACETOGLYCERIDZUSAMMENSETZUNG ENTHALTEND EINEN HOHEN ANTEIL AN MONOACETYLMONOACYLGLYCERIDE PROCÉDÉ POUR LA PRÉPARATION D’UNE COMPOSITION D’UN ACÉTOGLYCÉRIDE RICHE EN MONOACETYLMONOACYLGLYCERIDE (84) Designated Contracting States: (72) Inventors: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR • DIJKSTRA, Albert Jan HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI F-47210 St. Eutrope-de-born (FR) SK TR • BROCKE, Petrus Conradus NL-1705 NS Heerhugowaard (NL) (30) Priority: 13.01.2005 EP 05075100 • WOLDHUIS, Jan NL-1827 MG Alkmaar (NL) (43) Date of publication of application: 03.10.2007 Bulletin 2007/40 (74) Representative: Nederlandsch Octrooibureau P.O. Box 29720 (73) Proprietor: Paramelt B.V. 2502 LS The Hague (NL) 1704 RJ Heerhugowaard (NL) (56) References cited: US-A- 2 764 605 US-A- 5 434 278 Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations.
    [Show full text]
  • 6 Minute Walk Results
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date r i 1 /1 i 22 December 2011 (22.12.2011) » 2U1 1/159634ft Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/23 (2006.01) A61P 3/00 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, PCT/US201 1/040234 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, JL, IN, IS, JP, KE, KG, KM, KN, KP, 13 June 201 1 (13.06.201 1) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (26) Publication Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 61/354,472 14 June 2010 (14.06.2010) US (84) Designated States (unless otherwise indicated, for every 13/159,329 13 June 201 1 (13.06.201 1) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, (71) Applicant (for all designated States except US): BAY¬ ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, LOR RESEARCH INSTITUTE [US/US]; 33 10 Live TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Oak Street, Suite 501, Dallas, TX 75204 (US).
    [Show full text]
  • Chemoprevention in Kidney Cancer by Madhur Nayan
    Chemoprevention in Kidney Cancer by Madhur Nayan A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy in Clinical Epidemiology, Graduate Department of Health Policy, Management, and Evaluation, in the University of Toronto © Copyright by Madhur Nayan, 2017 THESIS ABSTRACT Thesis Title: Chemoprevention in kidney cancer Degree: Doctor of Philosophy (PhD) in Clinical Epidemiology Year of Convocation: 2017 Student: Madhur Nayan Graduate Department: Health Policy, Management and Evaluation University: University of Toronto Background: This thesis is a composition of three studies that explore the role of statins in kidney cancer. Furthermore, I evaluate the potential for different interpretations from the same data depending on the method of classifying medication use. Methods: The first study was a population-based case-control study evaluating the association of statin use with risk of incident kidney cancer. The second study was a systematic review and meta-analysis reviewing the current evidence relating statins with kidney cancer survival outcomes. The final study was a population-based cohort study evaluating the association of statin use with survival. In the observational studies, I used fractional polynomials for the primary analysis to allow for a non-linear relationship between cumulative exposure and the risk of the outcome. I also compared risk estimates obtained by different methods of classifying medication exposure. Results: The population-based case-control study included 10,377 incident cases of kidney cancer and 35,939 matched controls. Increasing cumulative use of statins was not associated with kidney cancer risk. I identified 12 studies for inclusion in the systematic review and meta- analysis and found that statin use was significantly associated with markedly improved cancer- specific and overall survival.
    [Show full text]